New Antiarrhythmic Drugs for Atrial Flutter and Atrial Fibrillation
- 22 January 2002
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 105 (3) , 276-278
- https://doi.org/10.1161/circ.105.3.276
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Preferential Depression of Conduction Around a Pivot Point in Rabbit Ventricular Myocardium by Potassium and FlecainideJournal of Cardiovascular Electrophysiology, 2000
- Conversion Efficacy and Safety of Intravenous Ibutilide Compared With Intravenous Procainamide in Patients With Atrial Flutter or Fibrillation 11This study was sponsored by Pharmacia & Upjohn, Kalamazoo, Michigan.22See Appendix Afor a complete list of investigators and study sites.Journal of the American College of Cardiology, 1998
- Atrial Flutter Mapping and Ablation IPacing and Clinical Electrophysiology, 1996
- Vortex shedding as a precursor of turbulent electrical activity in cardiac muscleBiophysical Journal, 1996
- Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainidePublished by Elsevier ,1994
- Comparison of the usefulness of the implantable cardioverter-defibrillator and subendocardial resection in patients with sustained ventricular arrhythmias and poor regional wall motion associated with coronary artery diseaseThe American Journal of Cardiology, 1993
- The value of the clinical history to assess prognosis of patients with ventricular tachycardia or ventricular fibrillation after myocardial infarctionEuropean Heart Journal, 1989
- Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythmThe American Journal of Cardiology, 1989
- Classification of Antiarrhythmic ActionsPublished by Springer Nature ,1989
- Prognosis following sustained ventricular tachycardia occurring early after myocardial infarctionThe American Journal of Cardiology, 1988